Literature DB >> 26383606

Serine 220 phosphorylation of the Merkel cell polyomavirus large T antigen crucially supports growth of Merkel cell carcinoma cells.

David Schrama1, Sonja Hesbacher1, Sabrina Angermeyer1, Andreas Schlosser2, Sebastian Haferkamp3, Annemarie Aue1, Christian Adam1, Alexandra Weber1, Marc Schmidt1, Roland Houben1.   

Abstract

Merkel cell polyomavirus (MCPyV) is regarded as a major causal factor for Merkel cell carcinoma (MCC). Indeed, tumor cell growth of MCPyV-positive MCC cells is dependent on the expression of a truncated viral Large T antigen (LT) with an intact retinoblastoma protein (RB)-binding site. Here we determined the phosphorylation pattern of a truncated MCPyV-LT characteristically for MCC by mass spectrometry revealing MCPyV-LT as multi-phospho-protein phosphorylated at several serine and threonine residues. Remarkably, disruption of most of these phosphorylation sites did not affect its ability to rescue knockdown of endogenous T antigens in MCC cells indicating that phosphorylation of the respective amino acids is not essential for the growth promoting function of MCPyV-LT. However, alteration of serine 220 to alanine completely abolished the ability of MCPyV-LT to support proliferation of MCC cells. Conversely, mimicking the phosphorylated state by mutation of serine 220 to glutamic acid resulted in a fully functional LT. Moreover, MCPyV-LT(S220A) demonstrated reduced binding to RB in co-immunoprecipitation experiments as well as weaker induction of RB target genes in MCC cells. In conclusion, we provide evidence that phosphorylation of serine 220 is required for efficient RB inactivation in MCC and may therefore be a potential target for future therapeutic approaches.
© 2015 UICC.

Entities:  

Keywords:  Large T antigen; merkel cell carcinoma; phosphorylation; polyomavirus

Mesh:

Substances:

Year:  2015        PMID: 26383606     DOI: 10.1002/ijc.29862

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.

Authors:  Jürgen C Becker; Andreas Stang; Axel Zur Hausen; Nicole Fischer; James A DeCaprio; Richard W Tothill; Rikke Lyngaa; Ulla Kring Hansen; Cathrin Ritter; Paul Nghiem; Christopher K Bichakjian; Selma Ugurel; David Schrama
Journal:  Cancer Immunol Immunother       Date:  2017-11-30       Impact factor: 6.968

2.  Human CD4+ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain.

Authors:  Paul Nghiem; William W Kwok; David M Koelle; Natalie V Longino; Junbao Yang; Jayasri G Iyer; Dafina Ibrani; I-Ting Chow; Kerry J Laing; Victoria L Campbell; Kelly G Paulson; Rima M Kulikauskas; Candice D Church; Eddie A James
Journal:  Cancer Immunol Res       Date:  2019-08-12       Impact factor: 11.151

3.  Protein-mediated viral latency is a novel mechanism for Merkel cell polyomavirus persistence.

Authors:  Hyun Jin Kwun; Yuan Chang; Patrick S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

Review 4.  From Merkel Cell Polyomavirus Infection to Merkel Cell Carcinoma Oncogenesis.

Authors:  Nathan A Krump; Jianxin You
Journal:  Front Microbiol       Date:  2021-09-08       Impact factor: 6.064

5.  Merkel cell polyomavirus large T antigen binding to pRb promotes skin hyperplasia and tumor development.

Authors:  Megan E Spurgeon; Jingwei Cheng; Ella Ward-Shaw; Frederick A Dick; James A DeCaprio; Paul F Lambert
Journal:  PLoS Pathog       Date:  2022-05-13       Impact factor: 7.464

Review 6.  Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.

Authors:  Aric Colunga; Thomas Pulliam; Paul Nghiem
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

Review 7.  Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.

Authors:  Natalie Vandeven; Paul Nghiem
Journal:  Immunotherapy       Date:  2016-07       Impact factor: 4.196

8.  RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells.

Authors:  Sonja Hesbacher; Lisa Pfitzer; Katharina Wiedorfer; Sabrina Angermeyer; Andreas Borst; Sebastian Haferkamp; Claus-Jürgen Scholz; Marion Wobser; David Schrama; Roland Houben
Journal:  Oncotarget       Date:  2016-05-31

9.  Merkel cell polyomavirus Tumor antigens expressed in Merkel cell carcinoma function independently of the ubiquitin ligases Fbw7 and β-TrCP.

Authors:  Kristine N Dye; Markus Welcker; Bruce E Clurman; Ann Roman; Denise A Galloway
Journal:  PLoS Pathog       Date:  2019-01-28       Impact factor: 6.823

10.  Merkel Cell Polyomavirus Large T Antigen Unique Domain Regulates Its Own Protein Stability and Cell Growth.

Authors:  Nnenna Nwogu; Luz E Ortiz; Hyun Jin Kwun
Journal:  Viruses       Date:  2020-09-18       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.